Zobrazeno 1 - 2
of 2
pro vyhledávání: '"ROS1-FBXL17 fusion"'
Autor:
Qiang Zhang, Shi Xin Yan, Ying Ying Cheng, Hui Li, Zhicheng Huang, Ying Liu, Jinhua Xu, Shaowei Lan
Publikováno v:
OncoTargets and therapy
Purpose The rearrangement of ROS1 (C-ros oncogene 1) is an important driver of non-small cell lung cancer (NSCLC). Currently, only approximately 24 ROS1 fusion partners have been shown to be sensitive to crizotinib. Although fusion partner determinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b86ca1413edee3a8b90d810a42efd05
https://doi.org/10.2147/ott.s278907
https://doi.org/10.2147/ott.s278907
Publikováno v:
OncoTargets and Therapy, Vol Volume 13, Pp 11499-11504 (2020)
Shaowei Lan,1,2,* Hui Li,1,2,* Ying Liu,3 Jinhua Xu,3 Zhicheng Huang,4 Shi Yan,1,2 Qiang Zhang,5 Ying Cheng1– 3 1Translational Oncology Research Lab, Jilin Provincial Cancer Hospital, Changchun 130012, People’s Republic of China; 2Jilin Provincia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::b4dcadf18f0dcea88643dc96a9cdab8b
https://www.dovepress.com/a-novel-ros1-fbxl17-fusion-co-existing-with-cd74-ros1-fusion-may-impro-peer-reviewed-article-OTT
https://www.dovepress.com/a-novel-ros1-fbxl17-fusion-co-existing-with-cd74-ros1-fusion-may-impro-peer-reviewed-article-OTT